PlainRecalls

Upsher Smith Laboratories, Inc.

Compiled from official public sources by the publisher.

6 recalls on record · Latest: Aug 28, 2019

Subscribe to new Upsher Smith Laboratories,… recalls (RSS)

Agency notice ledger

Federal filing book Upsher Smith Laboratories,… LIGHT-BOOK · SINGLE-AGENCY

#2,327 of 14,151 · 6 notices · 0.006% archive

  • BOOK 6 notices
  • RANK #2,327 of 14,151
  • SHARE 0.006% archive
  • AGENCY FDA Drug (6)
  • CAT children
  • CATS 2 categories
  • LATEST Aug 28, 2019
  • PHOTO 1908 Brands

Nearest notice-volume peer: 1908 Brands (0 notice gap)

Upsher Smith Laboratories, Inc. accounts for about 0.006% of the 104,423-notice archive on 6 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Upsher Smith Laboratories,…'s standing among 14,151 recalling firms

Upsher Smith Laboratories, Inc. ranks 2,327th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Upsher Smith Laboratories,… vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

6 2327th of 14151 higher than 11,804 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Upsher Smith Laboratories,… in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Upsher Smith Laboratories, Inc. holds about 0.006% of archive notices alongside 6 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Aug 28, 2019

Bexarotene Capsules, 75 mg, 100 capsules per bottle, Rx Only, Manufactured for: Upsher-Smith Laboratories, LLC, Maple Grove, MN 55369. NDC: 0832-0285-00
FDA Drug Moderate Oct 31, 2018

Bumetanide Tablets, USP, 2 mg, 100-count bottle, Rx only, Manufactured by: Upser-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC 0832-0542-11
FDA Drug Moderate Oct 31, 2018

Bumetanide Tablets, USP, 1 mg, 100-count bottle, Rx only, Manufactured by: Upser-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC 0832-0541-11
FDA Drug Low Apr 30, 2014

Oxandrolone Tablets, USP, 10 mg, Rx Only, C-III, 60-count bottle, Manufactured for: Upsher-Smith Labs, Minneapolis, MN 55447, by: Pharmaceutics International, Inc., Hunt Valley, MD 21031, NDC 0245-0272-06
FDA Drug Moderate Feb 20, 2013

Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, Rx only, Manufactured for Upsher Smith Laboratories, Inc Minneapolis MN 55447 --- NDC 0245-0085-11, UPC 3 0245-0085-11 9
FDA Drug Low Jan 23, 2013

Divalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 100-count tablets per bottle, Rx only, Manufactured by Upsher-Smith Laboratories, Inc., Minneapolis, MN 55447, NDC 0245-0182-11.

Upsher Smith Laboratories,… holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (6 here).

1908 Brands 6 Abbott Molecular 6 Accriva Diagnostics, Inc. 6 Advance Medical Designs, Inc. 6 Agave Dream 6

Frequently Asked Questions

How many federal recall notices name Upsher Smith Laboratories,…? ▼
PlainRecalls indexes 6 distinct federal recall events naming Upsher Smith Laboratories, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Upsher Smith Laboratories,… sit among other recalling firms? ▼
Upsher Smith Laboratories, Inc. ranks #2,327 of 14,151 by distinct recall-event count among 14,151 firms in this archive (83rd percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Upsher Smith Laboratories,…'s notices? ▼
FDA Drug accounts for 6 of this firm's 6 indexed notices.
What product category dominates Upsher Smith Laboratories,…'s filing book? ▼
Filings for Upsher Smith Laboratories, Inc. span 2 product categories, led by children. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Upsher Smith Laboratories, Inc.: 6 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Upsher Smith Laboratories, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026